{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:18:49Z","timestamp":1773213529835,"version":"3.50.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1093\/toxsci\/kfs232","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T11:33:31Z","timestamp":1343475211000},"page":"106-116","source":"Crossref","is-referenced-by-count":92,"title":["Three-Dimensional HepaRG Model As An Attractive Tool for Toxicity Testing"],"prefix":"10.1093","volume":"130","author":[{"given":"Sofia B.","family":"Leite","sequence":"first","affiliation":[]},{"given":"Iwona","family":"Wilk-Zasadna","sequence":"additional","affiliation":[]},{"given":"Jose M.","family":"Zaldivar","sequence":"additional","affiliation":[]},{"given":"Elodie","family":"Airola","sequence":"additional","affiliation":[]},{"given":"Marcos A.","family":"Reis-Fernandes","sequence":"additional","affiliation":[]},{"given":"Milena","family":"Mennecozzi","sequence":"additional","affiliation":[]},{"given":"Christiane","family":"Guguen-Guillouzo","sequence":"additional","affiliation":[]},{"given":"Christopher","family":"Chesne","sequence":"additional","affiliation":[]},{"given":"Claude","family":"Guillou","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Coecke","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2012,7,27]]},"reference":[{"key":"key\n\t\t\t\t20170315204548_CIT0001","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tiv.2009.05.021","article-title":"Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.","volume":"24","author":"Abadie-Viollon","year":"(2010)","journal-title":"Toxicol. In Vitro"},{"key":"key\n\t\t\t\t20170315204548_CIT0002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tox.2012.01.010","article-title":"Characterization of human cytochrome P450 induction by pesticides.","volume":"294","author":"Abass","year":"(2012)","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20170315204548_CIT0003","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00204-011-0693-2","article-title":"Alternative (non-animal) methods for cosmetics testing: Current status and future prospects-2010.","volume":"85","author":"Adler","year":"(2011)","journal-title":"Arch. Toxicol."},{"key":"key\n\t\t\t\t20170315204548_CIT0004","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00228-006-0127-x","article-title":"Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: Studies with tizanidine and caffeine.","volume":"62","author":"Backman","year":"(2006)","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"key\n\t\t\t\t20170315204548_CIT0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/026119290703500606","article-title":"Physiologically-based kinetic modelling (PBK Modelling): Meeting the 3Rs agenda. The report and recommendations of ECVAM Workshop 63.","volume":"35","author":"Bouvier d\u2019Yvoire","year":"(2007)","journal-title":"Altern. Lab. Anim."},{"key":"key\n\t\t\t\t20170315204548_CIT0006","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/bdd.1767","article-title":"Physiologically based pharmacokinetic (PBPK) modelling tools: How to fit with our needs?","volume":"33","author":"Bouzom","year":"(2012)","journal-title":"Biopharm. Drug Dispos."},{"key":"key\n\t\t\t\t20170315204548_CIT0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/bdd.1769","article-title":"Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: Strategy and approach during the drug discovery phase with four case studies.","volume":"33","author":"Chen","year":"(2012)","journal-title":"Biopharm. Drug Dispos."},{"key":"key\n\t\t\t\t20170315204548_CIT0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/026119290603400113","article-title":"Metabolism: A bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54.","volume":"34","author":"Coecke","year":"(2006)","journal-title":"Altern. Lab. Anim."},{"key":"key\n\t\t\t\t20170315204548_CIT0009","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1124\/dmd.110.037721","article-title":"Cytochrome P450-dependent metabolism in HepaRG cells cultured in a dynamic three-dimensional bioreactor.","volume":"39","author":"Darnell","year":"(2011)","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20170315204548_CIT0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00008571-200310000-00003","article-title":"Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.","volume":"13","author":"Floyd","year":"(2003)","journal-title":"Pharmacogenetics"},{"key":"key\n\t\t\t\t20170315204548_CIT0011","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.tiv.2010.08.007","article-title":"Validation of reference gene stability for APAP hepatotoxicity studies in different in vitro systems and identification of novel potential toxicity biomarkers.","volume":"24","author":"Fox","year":"(2010)","journal-title":"Toxicol. In Vitro"},{"key":"key\n\t\t\t\t20170315204548_CIT0012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins.","volume":"28","author":"Gerets","year":"(2012)","journal-title":"Cell Biol. Toxicol."},{"key":"key\n\t\t\t\t20170315204548_CIT0013","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/adc.2007.126896","article-title":"Paracetamol (acetaminophen) pharmacodynamics: Interpreting the plasma concentration.","volume":"93","author":"Gibb","year":"(2008)","journal-title":"Arch. Dis. Child."},{"key":"key\n\t\t\t\t20170315204548_CIT0014","first-page":"596","article-title":"An improved assay of 7-ethoxycoumarin O-deethylase activity: Induction of hepatic enzyme activity in C57BL\/6J and DBA\/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin.","volume":"205","author":"Greenlee","year":"(1978)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20170315204548_CIT0015","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus.","volume":"99","author":"Gripon","year":"(2002)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20170315204548_CIT0016","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.biocel.2011.06.011","article-title":"The HepaRG cell line is suitable for bioartificial liver application.","volume":"43","author":"Hoekstra","year":"(2011)","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"key\n\t\t\t\t20170315204548_CIT0017","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1089\/ten.tea.2008.0403","article-title":"An approach for formation of vascularized liver tissue by endothelial cell-covered hepatocyte spheroid integration.","volume":"15","author":"Inamori","year":"(2009)","journal-title":"Tissue Eng. Part A"},{"key":"key\n\t\t\t\t20170315204548_CIT0018","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/dmd.107.020016","article-title":"Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies.","volume":"36","author":"Kanebratt","year":"(2008)","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20170315204548_CIT0019","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity.","volume":"4","author":"Kaplowitz","year":"(2005)","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t20170315204548_CIT0020","volume-title":"The Analysis of Aquatic Toxicity Data","author":"Kooijman","year":"(1996)"},{"key":"key\n\t\t\t\t20170315204548_CIT0021","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.taap.2008.11.008","article-title":"Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells.","volume":"234","author":"Lambert","year":"(2009)","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"key\n\t\t\t\t20170315204548_CIT0022","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI3703","article-title":"The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.","volume":"102","author":"Lehmann","year":"(1998)","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170315204548_CIT0023","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.tiv.2011.02.002","article-title":"Merging bioreactor technology with 3D hepatocyte-fibroblast culturing approaches: Improved in vitro models for toxicological applications.","volume":"25","author":"Leite","year":"(2011)","journal-title":"Toxicol. In Vitro"},{"key":"key\n\t\t\t\t20170315204548_CIT0024","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vascn.2010.04.013","article-title":"HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.","volume":"63","author":"Lubberstedt","year":"(2011)","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20170315204548_CIT0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/026119291103900210","article-title":"Toward preclinical predictive drug testing for metabolism and hepatotoxicity by using in vitro models derived from human embryonic stem cells and human cell lines\u2014A report on the Vitrocellomics EU-project.","volume":"39","author":"Mandenius","year":"(2011)","journal-title":"Altern. Lab. Anim."},{"key":"key\n\t\t\t\t20170315204548_CIT0026","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.24132","article-title":"HepaRG cells: A human model to study mechanisms of acetaminophen hepatotoxicity.","volume":"53","author":"McGill","year":"(2011)","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170315204548_CIT0027","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/ten.tec.2008.0352","article-title":"Towards an extended functional hepatocyte in vitro culture.","volume":"15","author":"Miranda","year":"(2009)","journal-title":"Tissue Eng. Part C. Methods"},{"key":"key\n\t\t\t\t20170315204548_CIT0028","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1124\/dmd.111.038059","article-title":"Quantitative time-lapse imaging-based analysis of drug-drug interaction mediated by hepatobiliary transporter, multidrug resistance-associated protein 2, in sandwich-cultured rat hepatocytes.","volume":"39","author":"Nakanishi","year":"(2011)","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20170315204548_CIT0029","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bmj.1.5853.587","article-title":"Pharmacological modification of gastric emptying: Effects of propantheline and metoclopromide on paracetamol absorption.","volume":"1","author":"Nimmo","year":"(1973)","journal-title":"Br. Med. J."},{"key":"key\n\t\t\t\t20170315204548_CIT0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/bj3290017","article-title":"Zonation of hepatic cytochrome P-450 expression and regulation.","volume":"329 (Pt 1)","author":"Oinonen","year":"(1998)","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t20170315204548_CIT0031","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/10408440802194931","article-title":"Local kinetics and dynamics of xenobiotics.","volume":"38","author":"Pelkonen","year":"(2008)","journal-title":"Crit. Rev. Toxicol."},{"key":"key\n\t\t\t\t20170315204548_CIT0032","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2011.04.018","article-title":"Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with JC-1 dye.","volume":"254","author":"Pernelle","year":"(2011)","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"key\n\t\t\t\t20170315204548_CIT0033","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tiv.2009.05.022","article-title":"Inter-laboratory evaluation of the response of primary human hepatocyte cultures to model CYP inducers\u2014A European Centre for Validation of Alternative Methods (ECVAM) - funded pre-validation study.","volume":"24","author":"Richert","year":"(2010)","journal-title":"Toxicol. In Vitro"},{"key":"key\n\t\t\t\t20170315204548_CIT0034","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.24707","article-title":"Hepatocyte polarization is essential for the productive entry of the hepatitis B virus.","volume":"55","author":"Schulze","year":"(2011)","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170315204548_CIT0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10544-011-9517-7","article-title":"\u201cArtificial micro organs\u201d\u2014A microfluidic device for dielectrophoretic assembly of liver sinusoids.","volume":"13","author":"Schutte","year":"(2011)","journal-title":"Biomed. Microdevices"},{"key":"key\n\t\t\t\t20170315204548_CIT0036","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1002\/jnr.21451","article-title":"Novel culture strategy for human stem cell proliferation and neuronal differentiation.","volume":"85","author":"Serra","year":"(2007)","journal-title":"J. Neurosci. Res."},{"key":"key\n\t\t\t\t20170315204548_CIT0037","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/bit.22920","article-title":"Perfusion of 3D encapsulated hepatocytes\u2013a synergistic effect enhancing long-term functionality in bioreactors.","volume":"108","author":"Tost\u00f5es","year":"(2011)","journal-title":"Biotechnol. Bioeng."},{"key":"key\n\t\t\t\t20170315204548_CIT0038","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.24760","article-title":"Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing.","volume":"55","author":"Tost\u00f5es","year":"(2012)","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170315204548_CIT0039","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/dmd.111.041137","article-title":"Acetaminophen-induced hepatotoxicity in a liver tissue model consisting of primary hepatocytes assembling around an endothelial cell network.","volume":"40","author":"Toyoda","year":"(2012)","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20170315204548_CIT0040","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.tiv.2009.03.008","article-title":"Functional expression, inhibition and induction of CYP enzymes in HepaRG cells.","volume":"23","author":"Turpeinen","year":"(2009)","journal-title":"Toxicol. In Vitro"},{"key":"key\n\t\t\t\t20170315204548_CIT0041","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clpt.2004.03.009","article-title":"Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states.","volume":"76","author":"Yu","year":"(2004)","journal-title":"Clin. Pharmacol. Ther."},{"key":"key\n\t\t\t\t20170315204548_CIT0042","article-title":"A biology-based dynamic approach for the modelling of toxicity in cell-based assays. Part II: Models for cell population growth and toxicity","author":"Zaldivar","year":"(2011)"},{"key":"key\n\t\t\t\t20170315204548_CIT0043","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/ten.tec.2010.0580","article-title":"Scaling down of a clinical three-dimensional perfusion multicompartment hollow fiber liver bioreactor developed for extracorporeal liver support to an analytical scale device useful for hepatic pharmacological in vitro studies.","volume":"17","author":"Zeilinger","year":"(2011)","journal-title":"Tissue Eng. Part C. Methods"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/130\/1\/106\/10996880\/kfs232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T15:31:33Z","timestamp":1594481493000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/1667624\/Three-Dimensional"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,7,27]]},"published-print":{"date-parts":[[2012,11]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfs232","relation":{},"ISSN":["1096-0929","1096-6080"],"issn-type":[{"value":"1096-0929","type":"electronic"},{"value":"1096-6080","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,27]]}}}